Live Breaking News & Updates on அகட சிகிச்சை இன்க்
Stay updated with breaking news from அகட சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABCL) - The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Acorda: Q4 Earnings Snapshot FacebookTwitterEmail ARDSLEY, N.Y. (AP) Acorda Therapeutics Inc. (ACOR) on Thursday reported fourth-quarter profit of $83 million. On a per-share basis, the Ardsley, New York-based company said it had net income of $9.82. Losses, adjusted for non-recurring gains, came to $2.50 per share. The drugmaker posted revenue of $38.2 million in the period. For the year, the company reported that its loss narrowed to $99.6 million, or $12.32 per share. Revenue was reported as $153 million. Acorda shares have climbed 64% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.78, a drop of 10% in the last 12 months. ....
Posted on 321 Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the sale of its manufacturing operations in Chelsea, Massachusetts to Catalent. Under the terms of the agreement, Catalent has paid Acorda $80 million in cash, resulting in expected net proceeds to Acorda of approximately $74 million after transaction fees and expenses and settlement of customary post-closing adjustments. In connection with the sale, Acorda and Catalent have entered into a long-term global supply agreement under which Catalent will manufacture and package INBRIJA for Acorda, ensuring an uninterrupted drug supply for Acorda’s patients and continued adherence to best-in-class manufacturing quality and safety standards. ....
Parkinson’s Disease Market report profiles topmost manufactures operating in terms of various attributes such as Company Overview, Financial Overview, ....